Table 3.
Differential metabolite signatures of lufenuron-treated lice compared to controls.
| Metabolite | p-value | Log2 FC Lufenuron/Control |
|---|---|---|
| Phosphatidic acid (33:2) | 0.03 | −1.6 |
| Phosphatidic acid (39:6) | 0.04 | −1.4 |
| Phosphatidic acid (37:6) | 0.03 | −1.4 |
| Phosphatidic acid (39:7) | 0.03 | −1.4 |
| Phosphatidylglycerol (14:0) | 0.03 | −1.3 |
| PA 1-heptadecanoyl-2-(9Z-tetradecenoyl)-sn-glycero-3-phosphate | 0.04 | −1.3 |
| Phosphatidic acid (37:3) | 0.02 | −1.3 |
| 1,2-di-(9Z-octadecenoyl)- sn-glycero-3-pyrophosphate |
0.03 | −1.3 |
| Phosphatidic Acid (35:3) | 0.03 | −1.3 |
| Phosphatidylglycerol (32:0) | 0.01 | −1.3 |
| Phosphatidic Acid (35:1) | 0.03 | −1.2 |
| 814.683@2 | 0.01 | −0.93 |
| Phosphatidylethanolamine (18:4/20:3) | 0.02 | −0.90 |
| 306.145@4 | 0.03 | −0.87 |
| Trp-Ser-Ser | 0.005 | −0.84 |
| Arg-Met-Phe-Asp | 0.02 | −0.78 |
| Serine | 0.004 | −0.63 |
| 389.253@0.8 | 0.04 | −0.59 |
| Asn-Ile-Ile-Val | 0.03 | −0.41 |
| 2,3-Dihydro-5,5′,7,7′-tetrahydroxy-2-(4-hydroxyphenyl)[3,8′-bi-4H-1-benzopyran]-4,4′-dione | 0.01 | −0.37 |
| Palmitoleoyl Ethanolamide | 0.02 | 0.40 |
| Citronellyl anthranilate | 0.02 | 0.44 |
| 9-Hexadecenoylcarnitine | 0.004 | 0.52 |
| 2″-O-Acetylrutin | 0.04 | 0.53 |
| Leucine | 0.02 | 0.64 |
| 435.996@1.8 | 0.03 | 0.64 |
| Ile-Arg-Lys | 0.01 | 0.69 |
| 181.988@8.6 | 0.02 | 0.69 |
| Phosphatidylglycerol (42:11) | 0.04 | 0.84 |
| Lys-Lys-Met-Phe | 0.02 | 0.86 |
| 367.214@12.3 | 0.001 | 0.87 |
| Arg-Asn-Gln-Arg | 0.05 | 1.1 |
| 894.414@0.9 | 0.01 | 1.1 |
| Ile-His-Phe | 0.04 | 1.2 |
| 678.357@0.9 | 0.04 | 1.2 |
| 509.976@0.9 (lufenuron) | 0.0 | 2.8 |
| Mannose | 0.2 | 1.1 |
| Glucose | 0.5 | −0.19 |
| Glucosamine | 0.6 | −0.052 |
| Glucose-6-phosphate | 0.7 | 0.068 |